Below are the financial statements of ACADIA Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Product sales, net | 957.8a | 726.44a | 517.24a |
| Total revenues | 957.8a | 726.44a | 517.24a |
| Operating expenses | — | — | — |
| Cost of product sales | -81.84a | -41.64a | -10.17a |
| Research and development | -303.25a | -351.62a | -361.58a |
| Selling, general and administrative | -488.43a | -406.56a | -369.09a |
| Gain on sale of non-financial asset | -146.52a | 0a | 0a |
| Total operating expenses | -727a | -799.82a | -740.83a |
| Income (loss) from operations | 230.79a | -73.38a | -223.6a |
| Interest income, net | 25.46a | 17.23a | 6.61a |
| Other income | 1.82a | 5.11a | 3.54a |
| Income (loss) before income taxes | 258.08a | -51.04a | -213.44a |
| Income tax expense | -31.62a | -10.25a | -2.53a |
| Net income (loss) | 226.45a | -61.29a | -215.98a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ACADIA Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.